Nathan B. Fountain
Director · Acumen Pharmaceuticals, Inc.
- 2026
- Jun 10, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nathan B. Fountain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Derek M. Meisner - $105K in ABOS purchases and sales in the last 12 months
- Derrell Porter - $75K in ABOS purchases and sales in the last 12 months
- Daniel Joseph Oconnell - $22K in ABOS purchases and sales in the last 12 months
- Matt Zuga - $8K in ABOS purchases and sales in the last 12 months
- Eric Siemers - $6K in ABOS purchases and sales in the last 12 months
- Russell Barton - $5K in ABOS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nathan B. Fountain?
Nathan B. Fountain is a corporate insider, tracked as Director of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Nathan B. Fountain last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 2 filings going back to 2026.
Has Nathan B. Fountain been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($14K) across all tracked filings.
